Charles E. Jackson
Impact in
- Nephrology top 0.5%
- Parathyroid Disorders and Treatments
- Genetics top 0.5%
- Vascular Anomalies and Treatments
Papers in
-
- Thyroid Cancer Diagnosis and Treatment 31
- Genetics 31
- Genetic Associations and Epidemiology 15
- Vascular Anomalies and Treatments 6
- Co-authors
- Douglas A. Marchuk (6 shared papers)Mary E. Porteous (4 shared papers)Margaret A. Pericak‐Vance (13 shared papers)Carol J. Gallione (4 shared papers)Alan E. Guttmacher (5 shared papers)Armen H. Tashjian (9 shared papers)Paul J. Goodfellow (4 shared papers)Samuel A. Wells (3 shared papers)
- Journals
- The American Journal of Human Genetics (7 papers)Nature Genetics (6 papers)Human Molecular Genetics (5 papers)Human Mutation (4 papers)Annals of Human Genetics (4 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Charles E. Jackson
130 papers receiving 12.5k citations
Charles E. Jackson's Hit Papers
Peers
Comparison fields: 5 of 125
- Nephrology 1.5k
- Genetics 1.3k
- Endocrinology, Diabetes and Metabolism 2.2k
- Pathology and Forensic Medicine 1k
- Genetics 1.6k
Countries citing papers authored by Charles E. Jackson
This map shows the geographic impact of Charles E. Jackson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles E. Jackson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles E. Jackson more than expected).
Fields of papers citing papers by Charles E. Jackson
This network shows the impact of papers produced by Charles E. Jackson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles E. Jackson. The network helps show where Charles E. Jackson may publish in the future.
Co-authors
The 25 scholars most cited alongside Charles E. Jackson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 134 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1 Hit paper breakdown → | 1994 | 1247 |
| 2 | Mutations in the activin receptor–like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2 Hit paper breakdown → | 1996 | 924 |
| 3 | Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A Hit paper breakdown → | 1995 | 840 |
| 4 | 2002 | 607 | |
| 5 | Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC Hit paper breakdown → | 1994 | 547 |
| 6 | Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. | 1996 | 536 |
| 7 | Single missense mutation in the tyrosine kinasecatalytic domain of the RET protooncogene is associated with multiple endocrineneoplasia type 2B. Hit paper breakdown → | 1994 | 507 |
| 8 | 1994 | 411 | |
| 9 | Familial gastric cancer: overview and guidelines for management. | 1999 | 408 |
| 10 | C-Cell Hyperplasia Preceding Medullary Thyroid Carcinoma Hit paper breakdown → | 1973 | 399 |
| 11 | 1996 | 389 | |
| 12 | 1987 | 370 | |
| 13 | 2001 | 326 | |
| 14 | Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. | 1998 | 274 |
| 15 | A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC. | 1995 | 229 |
| 16 | Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21-q31. | 1995 | 222 |
| 17 | 1956 | 207 | |
| 18 | 1997 | 204 | |
| 19 | Parent-of-origin effects in multiple endocrine neoplasia type 2B. | 1994 | 190 |
| 20 | Hereditary hyperparathyroidism and multiple ossifying jaw fibromas: a clinically and genetically distinct syndrome. | 1990 | 187 |
About Charles E. Jackson
Charles E. Jackson is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics, Nephrology, Pathology and Forensic Medicine and Genetics, having authored 134 papers that have together received 13.6k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (31 papers), Parathyroid Disorders and Treatments (15 papers), Genetic Associations and Epidemiology (15 papers), Muscle Physiology and Disorders (14 papers), Gastric Cancer Management and Outcomes (13 papers), Genetic factors in colorectal cancer (12 papers), Neuroendocrine Tumor Research Advances (12 papers) and Vascular Anomalies and Treatments (6 papers). The work is most often cited by research in Nephrology (1.5k citations), Genetics (1.3k citations), Endocrinology, Diabetes and Metabolism (2.2k citations), Pathology and Forensic Medicine (1k citations) and Genetics (1.6k citations). Charles E. Jackson has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Douglas A. Marchuk, Mary E. Porteous, Margaret A. Pericak‐Vance, Carol J. Gallione, Alan E. Guttmacher, Armen H. Tashjian, Paul J. Goodfellow, Samuel A. Wells, Jonathan Neil Berg and Timothy T. Stenzel. Their work appears in journals such as The American Journal of Human Genetics, Nature Genetics, Human Molecular Genetics, Human Mutation and Annals of Human Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.